Literature DB >> 17287329

Detection of extended-spectrum beta-lactamases among Enterobacteriaceae by use of semiautomated microbiology systems and manual detection procedures.

Irith Wiegand1, Heinrich K Geiss, Dietrich Mack, Enno Stürenburg, Harald Seifert.   

Abstract

Three commercially available microbiology identification and susceptibility testing systems were compared with regard to their ability to detect extended-spectrum beta-lactamase (ESBL) production in Enterobacteriaceae, i.e., the Phoenix Automated Microbiology System (BD Diagnostic Systems, Sparks, MD), the VITEK 2 System (bioMérieux, Marcy l'Etoile, France), and the MicroScan WalkAway-96 System (Dade Behring, Inc., West Sacramento, CA), using routine testing panels. One hundred fifty putative ESBL producers were distributed blindly to three participating laboratories. Conventional phenotypic confirmatory tests such as the disk approximation method, the CLSI double-disk synergy test, and the Etest ESBL were also evaluated. Biochemical and molecular characterization of beta-lactamases performed at an independent laboratory was used as the reference method. One hundred forty-seven isolates of Escherichia coli, Klebsiella pneumoniae, Klebsiella oxytoca, Enterobacter cloacae, Enterobacter aerogenes, Citrobacter freundii, Serratia marcescens, Proteus mirabilis, Proteus vulgaris, and Morganella morganii were investigated. Of these isolates, 85 were identified as ESBL producers by the reference method. The remaining isolates were identified as non-ESBL producers; they were either hyperproducers of their chromosomal AmpC, Koxy, or SHV enzymes or lacked any detectable beta-lactamase activity. The system with the highest sensitivity for the detection of ESBLs was the Phoenix (99%), followed by the VITEK 2 (86%) and the MicroScan (84%); however, specificity was more variable, ranging from 52% (Phoenix) to 78% (VITEK 2). The performance of the semiautomated systems differed widely with the species investigated. The sensitivities of the conventional test methods ranged from 93 to 94%. The double-disk synergy test showed the highest specificity and positive predictive value among all test methods, i.e., 97% and 98%, respectively.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17287329      PMCID: PMC1865808          DOI: 10.1128/JCM.01988-06

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  28 in total

1.  False-positive extended-spectrum beta-lactamase tests for Klebsiella oxytoca strains hyperproducing K1 beta-lactamase.

Authors:  Nicola A C Potz; Melissa Colman; Marina Warner; Rosy Reynolds; David M Livermore
Journal:  J Antimicrob Chemother       Date:  2004-02-12       Impact factor: 5.790

2.  Properties of plasmids responsible for production of extended-spectrum beta-lactamases.

Authors:  G A Jacoby; L Sutton
Journal:  Antimicrob Agents Chemother       Date:  1991-01       Impact factor: 5.191

3.  Detection of genes coding for extended-spectrum SHV beta-lactamases in clinical isolates by a molecular genetic method, and comparison with the E test.

Authors:  M T Nüesch-Inderbinen; H Hächler; F H Kayser
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-05       Impact factor: 3.267

4.  A plasmid-mediated CMY-2 beta-lactamase from an Algerian clinical isolate of Salmonella senftenberg.

Authors:  J L Koeck; G Arlet; A Philippon; S Basmaciogullari; H V Thien; Y Buisson; J D Cavallo
Journal:  FEMS Microbiol Lett       Date:  1997-07-15       Impact factor: 2.742

5.  Extended broad-spectrum beta-lactamases conferring transferable resistance to newer beta-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns.

Authors:  V Jarlier; M H Nicolas; G Fournier; A Philippon
Journal:  Rev Infect Dis       Date:  1988 Jul-Aug

6.  Evolution of plasmid-coded resistance to broad-spectrum cephalosporins.

Authors:  C Kliebe; B A Nies; J F Meyer; R M Tolxdorff-Neutzling; B Wiedemann
Journal:  Antimicrob Agents Chemother       Date:  1985-08       Impact factor: 5.191

7.  Impact of the ampD gene and its product on beta-lactamase production in Enterobacter cloacae.

Authors:  K Peter; G Korfmann; B Wiedemann
Journal:  Rev Infect Dis       Date:  1988 Jul-Aug

8.  Evaluation of Oxoid combination discs for detection of extended-spectrum beta-lactamases.

Authors:  Yves De Gheldre; Véronique Avesani; Catherine Berhin; Michel Delmée; Youri Glupczynski
Journal:  J Antimicrob Chemother       Date:  2003-09-12       Impact factor: 5.790

9.  Effect of D240G substitution in a novel ESBL CTX-M-27.

Authors:  R Bonnet; C Recule; R Baraduc; C Chanal; D Sirot; C De Champs; J Sirot
Journal:  J Antimicrob Chemother       Date:  2003-05-29       Impact factor: 5.790

10.  Evaluation of a new cefepime-clavulanate ESBL Etest to detect extended-spectrum beta-lactamases in an Enterobacteriaceae strain collection.

Authors:  Enno Stürenburg; Ingo Sobottka; Djahesh Noor; Rainer Laufs; Dietrich Mack
Journal:  J Antimicrob Chemother       Date:  2004-05-18       Impact factor: 5.790

View more
  47 in total

1.  Evaluation of the VITEK 2 AST-N111 card for detection of extended-spectrum beta-lactamases (ESBLs) in Escherichia coli, Klebsiella pneumoniae, and Klebsiella oxytoca compared to ESBL Etests and combination disk methods.

Authors:  G Valenza; S Müller; C Schmitt; D Turnwald; T-T Lam; M Frosch; M Abele-Horn; Y Pfeifer
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-01-27       Impact factor: 3.267

Review 2.  Preventing the spread of multidrug-resistant gram-negative pathogens: recommendations of an expert panel of the German Society For Hygiene and Microbiology.

Authors:  Frauke Mattner; Franz-C Bange; Elisabeth Meyer; Harald Seifert; Thomas A Wichelhaus; Iris F Chaberny
Journal:  Dtsch Arztebl Int       Date:  2012-01-20       Impact factor: 5.594

3.  Comparison of Phoenix and VITEK 2 extended-spectrum-beta-lactamase detection tests for analysis of Escherichia coli and Klebsiella isolates with well-characterized beta-lactamases.

Authors:  Kenneth S Thomson; Nancy E Cornish; Seong G Hong; Kim Hemrick; Christian Herdt; Ellen S Moland
Journal:  J Clin Microbiol       Date:  2007-06-27       Impact factor: 5.948

4.  Fatal endocarditis due to extended spectrum betalactamase producing Klebsiella terrigena in a liver transplant recipient.

Authors:  Hannes Goegele; Elfriede Ruttmann; Jaime Aranda-Michel; Reinhold Kafka; Ingrid Stelzmueller; Hans Hausdorfer; Robert Sawyer; Raimund Margreiter; Hugo Bonatti
Journal:  Wien Klin Wochenschr       Date:  2007       Impact factor: 1.704

5.  Performance of the Phoenix bacterial identification system compared with disc diffusion methods for identifying extended-spectrum beta-lactamase, AmpC and KPC producers.

Authors:  Mark A Fisher; Paul D Stamper; Kristine M Hujer; Zachary Love; Ann Croft; Samuel Cohen; Robert A Bonomo; Karen C Carroll; Cathy A Petti
Journal:  J Med Microbiol       Date:  2009-06       Impact factor: 2.472

6.  Extended-spectrum Beta-lactamase detection with different panels for automated susceptibility testing and with a chromogenic medium.

Authors:  J Färber; K-A Moder; F Layer; I Tammer; W König; B König
Journal:  J Clin Microbiol       Date:  2008-09-24       Impact factor: 5.948

7.  Comparison of nine phenotypic methods for detection of extended-spectrum beta-lactamase production by Enterobacteriaceae.

Authors:  Hélène Garrec; Laurence Drieux-Rouzet; Jean-Louis Golmard; Vincent Jarlier; Jérôme Robert
Journal:  J Clin Microbiol       Date:  2011-01-19       Impact factor: 5.948

Review 8.  Expert systems in clinical microbiology.

Authors:  Trevor Winstanley; Patrice Courvalin
Journal:  Clin Microbiol Rev       Date:  2011-07       Impact factor: 26.132

Review 9.  The continuing challenge of ESBLs.

Authors:  Federico Perez; Andrea Endimiani; Kristine M Hujer; Robert A Bonomo
Journal:  Curr Opin Pharmacol       Date:  2007-09-17       Impact factor: 5.547

10.  Integrated detection of extended-spectrum-beta-lactam resistance by DNA microarray-based genotyping of TEM, SHV, and CTX-M genes.

Authors:  Dirk M Leinberger; Verena Grimm; Maya Rubtsova; Jan Weile; Klaus Schröppel; Thomas A Wichelhaus; Cornelius Knabbe; Rolf D Schmid; Till T Bachmann
Journal:  J Clin Microbiol       Date:  2009-12-09       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.